EC3 COST-MINIMIZATION ANALYSIS OF CAPECITABINE + OXALIPLATIN (XELOX) VS. INFUSIONAL 5-FU/LV + OXALIPLATIN (FOLFOX-6) AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER (MCRC) IN THE FRENCH SETTING

✍ Scribed by G Perrocheau; M Ducreux; M Hebbar; M Ychou; G Lledo; T Conroy; R Faroux; JY Douillard; A Pacull

• Book ID: 119595751
• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 73 KB
• Volume: 10
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)64890-5